Bright Horizons Family Solutions Inc. (BFAM) · Oct 29, 2026 · Earnings
Guidance cut — FY26 adjusted EPS $4.98-$5.03 vs. prior $5.05-$5.15
Bright Horizons earnings showed a modest adjusted EPS beat, but a major goodwill impairment and lower 2026 guidance expose pressure in center-based care.
Bright Horizons is trying to make faster-growing back-up care offset pressure in its traditional center-based child-care business, particularly weaker international operations. The quarter shows that strategy working operationally—but not enough to preserve the prior full-year outlook.
The underlying quarter was slightly better than consensus on earnings, not revenue. Adjusted EPS was $1.80 versus a published consensus of about $1.76, while revenue of $841.5 million was just below the roughly $842.7 million expectation. Back-up-care revenue rose 13% and helped lift adjusted EBITDA 5%, but the core center-based segment’s adjusted operating margin fell to 4% from 4% a year earlier. 〔0〕
| Q3 2026 | Q3 2025 | Consensus / prior guide | |
|---|---|---|---|
| Revenue (Financial Statements) | $841.5M (-0.1%) | $802.8M | ~$842.7M |
| Adjusted EPS (Non-GAAP Reconciliations) | $1.80 (+14.6%) | $1.57 | ~$1.76 |
| Adjusted EBITDA (Non-GAAP Reconciliations) | $163.3M (+4.6%) | $156.1M | |
| FY26 revenue guidance (Outlook) | $3.07B | $3.085B-$3.115B | |
| FY26 adjusted EPS guidance (Outlook) | $4.98-$5.03 | $5.05-$5.15 |
The major new information is the reset in the center-based business. Bright Horizons recorded a $290 million goodwill impairment in the quarter, tied primarily to revised long-term cash-flow projections for international operations, especially Australia. That turned reported operating income into a $187.1 million loss and net income into a $230.7 million loss, even though adjusted operating income increased to $130.2 million.
The guidance cut matters more than the adjusted EPS beat. Management reduced the full-year revenue outlook from the prior $3.085-$3.115 billion range to approximately $3.07 billion, and lowered adjusted EPS guidance from $5.05-$5.15 to $4.98-$5.03. The change is modest numerically, but it says the stronger back-up-care trend is not fully offsetting center closures, international weakness, higher interest costs, and safeguarding-related expenses.
Cash generation remains a cushion, but the capital allocation is now less forgiving. Operating cash flow reached $208.1 million in the first nine months, yet the company spent roughly $557.7 million on share repurchases and added $373.6 million of long-term borrowings. Cash ended the period at $119.2 million, while total debt and lease obligations increased from year-end.
Bottom line: The operating engine is holding together because back-up care is growing, and adjusted EPS narrowly beat expectations. But the impairment and lower full-year guidance expose a more serious weakening in center-based care, making this a negative update to the broader business story despite the quarterly adjusted beat.
Q4 report and 2027 outlook, early 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!